Banner 1140x138
ErnestoBoschErnesto Bosch

Medical Director of the Human Reproduction Unit of the Instituto Valenciano de Infertilidad.  University of Valencia. Spain

Ernesto Bosch was born in Philadelphia, USA, in 1968. He completed Medicine School at the University of Valencia in 1992 and from 1993 to 1997, did his Residency in Obstetrics and Gynaecology at Hospital La Fe, Valencia.  Ernesto trained in Human Reproduction at the Hospital of the University of Pennsylvania in 1997; and in 1999, he completed his doctoral thesis on the influence of LH in oocyte quality, with “cum laude” qualification, at the University of Valencia.  In January 2000, Ernesto joined the team at the Human Reproduction Unit of the Instituto Valenciano de Infertilidad in Valencia, Spain; in 2008 he obtained the title of Master in Research on Health Sciences, by the Autonomous University if Barcelona.  Dr. Bosch has published 62 papers in peer reviewed journals and written more than 50 book chapters in the field of IVF; has given over 250 lectures at international meetings around the world; He belongs to the Editorial Board of Fertility & Sterility, and Reproductive Biomedicine Online and is a regular reviewer for Human Reproduction, and Reproductive Biology and Endocrinology among others. He received the Scientific Program Prize Paper Award at the 2008 Annual Meeting of the American Society for Reproductive Medicine.  Belonged to the Special Interest Group on Reproductive Endocrinology of the Spanish Fertility Society, and currently to the Special Interest Group on Reproductive Endocrinology of ESHRE. He was the National Representative of the Spanish clinicians at the ESHRE committee between 2014 and 2016. In May 2010, Dr. Bosch was appointed Medical Director of the Human Reproduction Unit of the Instituto Valenciano de Infertilidad in Valencia.

In 2018 he has obtained an MBA on Healthcare Management by the IMF Business School and University Camilo José Cela from Madrid.


NAME: Ernesto Bosch Aparicio

BIRTHDATE: March, 9th, 1968

BIRTHPLACE: Philadelphia (PA), USA.

CURRENT WORKPLACE: Instituto Valenciano de Infertilidad. (IVI)

Plaza Policía Local, 3. 46015. Valencia. SPAIN.

Pone: +34 96 305 00 00

FAX: +34 96 305 09 00

e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

  • 1992: Licensed from Medical School. University of Valencia.
  • 1993: General Physician. Hospital Clínico Universitario. Valencia.
  • 1994-97: Residency on Obstetrics & Gynaecology. Hospital Universitario La Fe. Valencia.
  • 1995-96: Doctoral Courses. University of Valencia.
  • 1997: Clinical Fellowship on Human Reproduction at The Hospital of the University of Pennsylvania. Philadelphia. USA.
  • 1998: Staff at the Human Reproduction unit. Hospital Universitario La Fe. Valencia.
  • 1999: Postdoctoral Research Project: “Influence of intrafollicular LH on oocyte quality in In Vitro Fertilization” qualified with Excellent “cum laude” at the University of Valencia, under the direction of Prof. Alberto Romeu from Hospital Universitario La Fe of Valencia, and Prof. Luis Blasco from The Hospital of The University of Pennsylvania, Philadelphia, USA.
  • 2000-2009: Gynaecologist of The Human Reproduction Unit at The Instituto Valenciano de Infertilidad, Valencia. Spain.
  • 2010….Director of the Human Reproduction Unit at The Instituto Valenciano de Infertilidad, Valencia, Spain.
  • 1997-98: Statistical Methods in Health Sciences. (300 hours). Universidad Autónoma de Barcelona.
  • 1999-2000: Multivariate Analysis. (240 hours). Universidad Autónoma de Barcelona.
  • 2003: European Diplomat in Gynecological Endoscopy. Universidad de Alcalá de Henares, and University of Clermont-Ferrand
  • 2008: Master on Design of Research projects. Universidad Autónoma de Barcelona.
  • 2008: ASRM General Program Paper Prize.
  • 2018. MBA on Healthcare management. IMF Business School. Universidad Camilo José Cela. Madrid.


1: Bosch E, Havelock J, Martin FS, Rasmussen BB, Klein BM, Mannaerts B, Arce JC; ESTHER-2 Study Group. Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial. Reprod Biomed Online. 2018 Dec14. pii: S1472-6483(18)30605-9. doi: 10.1016/j.rbmo.2018.10.012. [Epub ahead of print].

2: Spanish Infertility SWOT Group (SISG), Checa MA, Bellver J, Bosch E, EspinósJJ, Fabregues F, Fontes J, García-Velasco J, Requena A. Hysteroscopic septumresection and reproductive medicine: A  SWOT analysis. Reprod Biomed Online. 2018 Dec;37(6):709-715. doi: 10.1016/j.rbmo.2018.09.013. Epub 2018 Oct 22.

3: Bosch E, Bulletti C, Copperman AB, Fanchin R, Yarali H, Petta CA, Polyzos NP, Shapiro D, Ubaldi FM, Garcia Velasco JA, Longobardi S, D'Hooghe T, Humaidan P; Delphi TTP Consensus Group. How time to healthy singleton delivery could affect decision-making during infertility treatment: a Delphi consensus. Reprod Biomed Online. 2018 Nov 7. pii: S1472-6483(18)30526-1. doi: 10.1016/j.rbmo.2018.09.019. [Epub ahead of print]

4: Labarta E, Marin D, Remohí J, Bosch E. Conventional versus minimal ovarian stimulation: an intra-patient comparison of ovarian response in poor-responder women according to Bologna Criteria. Reprod Biomed Online. 2018

Oct;37(4):434-441. doi: 10.1016/j.rbmo.2018.07.007. Epub 2018 Aug 23.

5: Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H, Bosch E, Garcia-Velasco J. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro

fertilization/intracytoplasmic sperm injection: a multicenter multinational

analysis including ∼15,000 women. Fertil Steril. 2018 Sep;110(4):661-670.e1. doi: 10.1016/j.fertnstert.2018.04.039.

  1. Drakopoulos P, Santos-Ribeiro S, Bosch E, Garcia-Velasco J, Blockeel C, Romito A, Tournaye H, Polyzos N. The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation . Front Endocrinol 2018; 9: 361.

7: Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, Bühler K, Ferraretti AP, De Placido G, Mollo A, Fischer R, Humaidan P; International Collaborative Group for the Study of r-hLH (iCOS-LH). Recombinant luteinizing hormonesupplementation in assisted reproductive technology: a systematic review. Fertil Steril. 2018 Apr;109(4):644-664.

8: Lawrenz B, Labarta E, Fatemi H, Bosch E. Premature progesterone elevation: targets and rescue strategies. Fertil Steril. 2018 Apr;109(4):577-582.

9: La Marca A, Blockeel C, Bosch E, Fanchin R, Fatemi HM, Fauser BC,

García-Velasco JA, Humaidan P, Tarlatzis BC, Nelson SM. Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates. Hum Reprod. 2018 May 1;33(5):982-983.

  1. Bosch E, Labarta E, Pellicer A. Does cumulative live birth plateau beyond a certain ovarian response? Fertil Steril. 2017 Dec;108(6):943
  1. Labarta E, Mariani G, Holtmann N, Celada P, Remohí J, Bosch E. Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study. Hum Reprod. 2017 Oct 13:1-6
  1. Labarta E, Bosch E, Mercader A, Alamá P, Mateu E, Pellicer A. A Higher Ovarian Response after Stimulation for IVF Is Related to a Higher Number of Euploid Embryos. Biomed Res Int. 2017;2017:5637923.
  1. Nyboe Andersen A, Nelson SM, Fauser BC, García-Velasco JA, Klein BM, Arce JC; ESTHER-1 study group. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril. 2017 Feb;107(2):387-396.
  1. Bosch E, Labarta E, Kolibianakis E, Rosen M, Meldrum D. Regimen of ovarian stimulation affects oocyte and therefore embryo quality. Fertil Steril. 2016.
  1. Garcia-Velasco JA, Bosch E. The necessity to define the sub-optimalresponders. Hum Reprod. 2015 Dec;30(12):2958.
  1. Martin J, Asan, Yi Y, Alberola T, Rodríguez-Iglesias B, Jiménez-Almazán J, Li Q, Du H, Alama P, Ruiz A, Bosch E, Garrido N, Simon C. Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology. Fertil Steril. 2015 Nov;104(5):1286-93.
  1. Garrido N, Bosch E, Alamá P, Ruiz A. The time to prevent mendelian genetic diseases from donated or own gametes has come. Fertil Steril. 2015. Oct;104(4):833-5.
  1. Bosch E, Nyboe Andersen A, Barri P, García-Velasco JA, de Sutter P,Fernández-Sánchez M, Visnova H, Klein BM, Mannaerts B, Arce JC. Follicular and endocrine dose-responses according to anti-Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049). Clin Endocrinol (Oxf). 2015 Jul 23. doi: 10.1111/cen.12864. [Epub ahead of print] PubMed PMID: 26202150.
  1. Bosch E. High responders and patients with a good prognosis are not immune to the negative impact on live birth rate of elevated P on the day of triggering.Fertil Steril. 2015 Jun;103(6):1423. doi: 10.1016/j.fertnstert.2015.03.031. Epub 2015 May 5. PubMed PMID: 25956373.
  1. Anderson RA, Anckaert E, Bosch E, Dewailly D, Dunlop CE, Fehr D, Nardo L, Smitz J, Tremellen K, Denk B, Geistanger A, Hund M. Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool. Fertil Steril. 2015 Apr;103(4):1074-1080.
  1. Simón C, Bosch E, Bellver J. Reply: Endometrial scratching for women with repeated implantation failure. Hum Reprod. 2014 Oct 14.
  1. Arce JC, Nyboe Andersen A, Fernández-Sánchez M, Visnova H, Bosch E, García-Velasco JA, Barri P, de Sutter P, Klein BM, Fauser BC. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, anti-Müllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2014 Sep 23 [Epub ahead of print]
  1. Requena A, Cruz M, Bosch E, Meseguer M, García-Velasco JA. High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study. Reprod Biol Endocrinol. 2014 Jul 26;12:69. doi: 10.1186/1477-7827-12-69. PubMed PMID: 25064138; PubMed Central PMCID: PMC4118192.
  1. Labarta E, Bosch E, Pellicer A. Impact of ovarian stimulation with gonadotrophins on embryo aneuploidy. Hum Reprod Update. 2014 Jul 10..[Epub ahead of print].
  1. Bosch E. Comment on 'Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years old or older undergoing IVF/ICSI: a randomized controlled multicentre study'. Hum Reprod. 2014 Mar;29(3):636-7.
  1. Bosch E. Does progesterone elevation compromise pregnancy rates in high responders? Insufficient evidence to draw a conclusion. Fertil Steril. 2014 Jan;101(1):e3-4.
  1. Nardo LG, Bosch E, Lambalk CB, Gelbaya TA. Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil (Camb). 2013 Sep;16(3):144-50.
  1. Muñoz E, Taboas E, Portela S, Aguilar J, Fernandez I, Muñoz L, Bosch E. Treatment of luteal phase defects in assisted reproduction. Curr Drug Targets. 2013 Jul;14(8):832-42.
  1. Rubio C, Bellver J, Rodrigo L, Bosch E, Mercader A, Vidal C, De Los Santos MJ, Giles J, Labarta E, Domingo J, Crespo J, Remohí J, Pellicer A, Simón C. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertil Steril. 2013 Apr;99(5):1400-7.
  1. Choi B, Bosch E, Lannon BM, Leveille MC, Wong WH, Leader A, Pellicer A, Penzias AS, Yao MW. Personalized prediction of first-cycle in vitro fertilization success. Fertil Steril. 2013 Mar 20. doi:pii: S0015-0282(13)00273-2.10.1016/j.fertnstert.2013.02.016. [Epub ahead of print] PubMed PMID: 23522806.
  1. De los Santos MJ, García-Laez V, Beltrán D, Labarta E, Zuzuarregui JL, Alamá P, Gámiz P, Crespo J, Bosch E, Pellicer A. The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: is it hypoandrogenic? Hum Reprod. 2013 Jan;28(1):224-9. doi: 10.1093/humrep/des349. Epub 2012 Sep 27. PubMed PMID: 23019297.
  1. Labarta E, Bosch E, Alamá P, Rubio C, Rodrigo L, Pellicer A. Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles. J Clin Endocrinol Metab. 2012 Oct;97(10):E1987-94. doi: 10.1210/jc.2012-1738. Epub 2012 Aug 3. PubMed PMID: 22865900; PubMed Central PMCID: PMC3462940.
  1. Bosch E. Can we skip weekends in GnRH antagonist cycles without compromising the final outcome? Fertil Steril. 2012 Jun;97(6):1299-300.
  1. Muñoz E, Bosch E, Fernandez I, Portela S, Ortiz G, Remohi J, Pellicer A. The role of LH in ovarian stimulation. Curr Pharm Biotechnol. 2012 Mar;13(3):409-16. Review. PubMed PMID: 21657991.
  1. Nardo LG, Fleming R, Howles CM, Bosch E, Hamamah S, Ubaldi FM, Hugues JN, Balen AH, Nelson SM. Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation. Reprod Biomed Online. 2011 Aug;23(2):141-8. doi: 10.1016/j.rbmo.2011.05.008. Epub 2011 May 19. PubMed PMID: 21665542.
  1. Labarta E, Martínez-Conejero JA, Alamá P, Horcajadas JA, Pellicer A, Simón C, Bosch E. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011 Jul;26(7):1813-25.
  1. Papanikolaou EG, Polyzos NP, Humaidan P, Pados G, Bosch E, Tournaye H, Tarlatzis B. Aromatase inhibitors in stimulated IVF cycles. Reprod Biol Endocrinol. 2011 Jun 21;9:85. doi: 10.1186/1477-7827-9-85. Review. PubMed PMID: 21693033; PubMed Central PMCID: PMC3150251.
  1. Bosch E, Ezcurra D. Individualised controlled ovarian stimulation (iCOS):

maximising success rates for assisted reproductive technology patients. Reprod Biol Endocrinol. 2011 Jun 21;9:82. doi: 10.1186/1477-7827-9-82. PubMed PMID: 21693025; PubMed Central PMCID: PMC3150250.

  1. Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Pellicer A. Impact luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril. 2011 Mar 1;95(3):1031-6. doi: 10.1016/j.fertnstert.2010.10.021. Epub 2010 Nov 10. PubMed PMID: 21067717.
  1. Gabbanini M, Privitera L, Monzó A, Higueras G, Fuster S, Garrido N, Bosch E, Pellicer A. The use of prediction models of spontaneous pregnancy in in vitro fertilization units reveals differences between the expected results of public and private clinics in Spain. Fertil Steril. 2010 Nov;94(6):2376-8. doi:10.1016/j.fertnstert.2010.02.038. Epub 2010 Mar 29. PubMed PMID: 20347077.
  1. Bellver J, Labarta E, Bosch E, Melo MA, Vidal C, Remohí J, Pellicer A. GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial. Fertil Steril. 2010 Aug;94(3):1065-71.
  1. Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J, Pellicer A.

Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum  Reprod. 2010 Aug;25(8):2092-100.

  1. Bosch E. Recombinant human follicular stimulating hormone and recombinant human luteinizing hormone in a 2:1 ratio combination. Pharmacological characteristics and clinical applications. Expert Opin Biol Ther. 2010 Jun;10(6):1001-9. doi: 10.1517/14712598.2010.485607. Review. PubMed
  1. Bosch E, Vidal C, Labarta E, Simon C, Remohi J, Pellicer A. Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists—a randomized study. Hum Reprod. 2008 Oct;23(10):2346-51.
  1. Soares SR, Velasco JA, Fernandez M, Bosch E, Remohí J, Pellicer A, Simón C. Clinical factors affecting endometrial receptiveness in oocyte donation cycles. Fertil Steril. 2008 Mar;89(3):491.
  1. Bosch E. Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al (2007). Hum Reprod Update. 2008 Mar-Apr;14(2):194-5; author reply 195-6. doi: 10.1093/humupd/dmm046. Epub 2008 Jan 28. PubMed PMID: 18230603.
  1. Bellver J, Melo MA, Bosch E, Serra V, Remohí J, Pellicer A. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril. 2007 Aug;88(2):446-51. Epub 2007 Apr 6. PubMed PMID: 17418840.
  1. Cobo A, Bosch E, Alvarez C, de los Santos MJ, Pellicer A, Remohí J. Effect of a sharp serum oestradiol fall before HCG administration during ovarian stimulation in donors. Reprod Biomed Online. 2007 Aug;15(2):169-74. PubMed
  1. Escribá MJ, Bellver J, Bosch E, Sánchez M, Pellicer A, Remohí J. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study. Fertil Steril. 2006 Jul;86(1):92-7.
  1. Melo MA, Meseguer M, Garrido N, Bosch E, Pellicer A, Remohí J. The

significance of premature luteinization in an oocyte-donation programme. Hum Reprod. 2006 Jun;21(6):1503-7.

  1. Simon C, Oberyé J, Bellver J, Vidal C, Bosch E, Horcajadas JA, Murphy C, Adams S, Riesewijk A, Mannaerts B, Pellicer A. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod. 2005 Dec;20(12):3318-27.
  1. Bellver J, Bosch E, Remohí J, Pellicer A. Evidence-based medicine is gaining momentum. Fertil Steril. 2005 Nov;84(5):1555-6; author reply 1556-7.
  1. Bosch E, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Serum luteinizing hormone in patients undergoing ovarian stimulation withgonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome. Fertil Steril. 2005 Nov;84(5):1529-32.
  1. Soares SR, Troncoso C, Bosch E, Serra V, Simón C, Remohí J, Pellicer A. Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. J Clin Endocrinol Metab. 2005 Jul;90(7):4399-404.
  1. Christiansen OB, Nybo Andersen AM, Bosch E, Daya S, Delves PJ, Hviid TV, Kutteh WH, Laird SM, Li TC, van der Ven K. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril. 2005 Apr;83(4):821-39. Review. PubMed PMID: 15820784.
  1. Bellver J, Bosch E, Pellicer A. BMI--the fragility of fertility. Fertil Steril. 2004 Mar;81(3):727; author reply 727-8. PubMed PMID: 15037438.
  1. Escudero E, Bosch E, Crespo J, Simón C, Remohí J, Pellicer A. Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients. Fertil Steril. 2004 Mar;81(3):562-6. PubMed PMID: 15037403.
  1. Bosch E, Valencia I, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003 Dec;80(6):1444-9. PubMed PMID: 14667881.
  1. Bellver J, Muñoz EA, Ballesteros A, Soares SR, Bosch E, Simón C, Pellicer A, Remohí J. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Hum Reprod. 2003 Nov;18(11):2283-8. PubMed PMID: 14585874.
  1. Bellver J, Rossal LP, Bosch E, Zúñiga A, Corona JT, Meléndez F, Gómez E, Simón C, Remohí J, Pellicer A. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003 May;79(5):1136-40.
  1. Troncoso C, Bosch E, Rubio C, Remohí J, Simón C, Pellicer A. The origin of biochemical pregnancies: lessons learned from preimplantation genetic diagnosis. Fertil Steril. 2003 Feb;79(2):449-50..
  1. Pellicer A, Navarro J, Bosch E, Garrido N, Garcia-Velasco JA, Remohí J, Simón C. Endometrial quality in infertile women with endometriosis. Ann N Y Acad Sci. 2001 Sep;943:122-30. Review.

CLINICAL STUDIES IN RELEVANT AREA (including responsibilities):

Endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles (2005). Sub-investigator.

Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome. (2005). Principal Investigator

Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists. (2008). Principal Investigator.

GnRH agonist administration at the time of implantation in intrauterine insemination cycles (2009) Sub-Investigator

Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles (2010). Principal Investigator.

Embryoaneuploidy in natural ve stimulated cycles (2009-2011) (sub-investigator)

Endometrial receptivity in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis (2011). Sub-investigator

Human derived recombinant FSH, Phase II (Study-9 by Ferring- 2012): Principal Investigator

Barusiban to prevent uterine contractions in IVF patients (Basic study, by Ferring, 2012-13). Principal investigator and signing investigator.

Serum AMH and correlation with antral follicle count (by Roche diagnosis 2013). Principal investigator.

Recombinant LH in low responders (by MerckSerono, 2014). Principal investigator

Human derived recombinant FSH, phase III (by Ferring, 2014). Principal investigator.

Luteal phase support with duphaston (Study Lottus-1 by Abbott, 2014). Principal investigator.

Placebo controlled study of nolasiban to improve pregnancy rates in women undergoing IVF/ICSI (Implant-2)

Ongoing pregnancy rates in oocyte donation according to serum P levels de day of embryo transfer. Sub investigator (2017)

Follicular steroidgenesis in controlled ovarian stimulation. Principal Investigator (2018).

Comparison of hhCG with hCG+ß in the early prediction of ongoing pregnancy after in-vitro fertilization and embryo transfer. Principal investigator. (2018)


Palacio de Congresos de Palma de Mallorca

Calle Felicià Fuster, 2.
07006 Palma (Illes Balears)
IVI2019 | All rights Reserved.